共 144 条
[1]
Thompson AM(2010)Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS) Breast Cancer Res 12 R92-592
[2]
Jordan LB(2012)Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer J Clin Oncol 30 587-306
[3]
Quinlan P(2009)HER-2/neu expression in primary and metastatic breast cancer Breast Cancer Res Treat 113 301-3023
[4]
Amir E(2013)Discordance in ERα, PR and HER2 receptor status across different distant breast cancer metastases within the same patient Ann Oncol 24 3017-580
[5]
Miller N(2018)Receptor conversion in distant breast cancer metastases: a systematic review and meta-analysis J Natl Cancer Inst 110 568-289
[6]
Geddie W(2014)A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases Eur J Cancer 50 277-2704
[7]
Lower EE(2015)Use of biomarkers to guide decisions on systemic therapy for women with metastatic breast cancer: American society of clinical oncology clinical practice guideline J Clin Oncol 33 2695-957
[8]
Glass E(2013)HER2 discordance between primary and metastatic breast cancer: assessing the clinical impact Cancer Treat Rev 39 947-1958
[9]
Blau R(2009)Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer Ann Oncol 20 1953-108
[10]
Hoefnagel LD(2013)Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: A single-institution analysis Ann Oncol 24 101-30